EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access

Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy

Giulia Turri, Giovanni Ostuzzi, Giovanni Vita, Valeria Barresi, Aldo Scarpa, Michele Milella, Renzo Mazzarotto, Andrea Ruzzenente, Corrado Barbui, Corrado Pedrazzani

JAMA Network Open · 04.06.2024 · 7 (6) · e2414702

DOI: 10.1001/jamanetworkopen.2024.14702 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA Network Open, online erschienen am 04.06.2024. Verfasst von Giulia Turri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, I…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Treatment of locally advanced rectal cancer (LARC) involves neoadjuvant chemoradiotherapy plus total mesorectal excision and adjuvant chemotherapy. However, total neoadjuvant therapy (TNT) protocols (ie, preoperative chemotherapy in addition to radiotherapy) may allow better adherence and early treatment of distant micrometastases and may increase pathological complete response (pCR) rates.

Objective

To assess the efficacy and tolerability of TNT protocols for LARC. Data Sources MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science Core Collection electronic databases and ClinicalTrials.gov for unpublished studies were searched from inception to March 2, 2024. Study Selection Randomized clinical trials including adults with LARC who underwent rectal resection as a final treatment were included. Studies including nonoperative treatment (watch-and-wait strategy), treatments other than rectal resection, immunotherapy, or antiangiogenic agents were excluded. Among the initially identified studies, 2.9% met the selection criteria. Data Extraction and Synthesis Two authors independently screened the records and extracted data. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA)–compliant pairwise and network meta-analyses with a random-effects model were performed in a frequentist framework, and the certainty of evidence was assessed according to the confidence in network meta-analysis approach. Main Outcomes and Measures The primary outcome was pCR, defined as the absence of residual tumor at pathological assessment after surgery. Secondary outcomes included tolerability, toxic effects, perioperative outcomes, and long-term survival.

Results

Of 925 records identified, 27 randomized clinical trials, including 13 413 adults aged 18 years or older (median age, 60.0 years [range, 42.0-63.5 years]; 67.2% male) contributed to the primary network meta-analysis. With regard to pCR, long-course chemoradiotherapy (L-CRT) plus consolidation chemotherapy (relative risk [RR], 1.96; 95% CI, 1.25-3.06), short-course radiotherapy (S-RT) plus consolidation chemotherapy (RR, 1.76; 95% CI, 1.34-2.30), and induction chemotherapy plus L-CRT (RR, 1.57; 95% CI, 1.09-2.25) outperformed standard L-CRT with single-agent fluoropyrimidine-based chemotherapy. Considering 3-year disease-free survival, S-RT plus consolidation chemotherapy (RR, 1.08; 95% CI, 1.01-1.14) and induction chemotherapy plus L-CRT (RR, 1.12; 95% CI, 1.01-1.24) outperformed L-CRT, in spite of an increased 5-year locoregional recurrence rate of S-RT plus consolidation chemotherapy (RR, 1.65; 95% CI, 1.03-2.63). Conclusions and Relevance In this systematic review and network meta-analysis, 3 TNT protocols were identified to outperform the current standard of care in terms of pCR rates, with good tolerability and optimal postoperative outcomes, suggesting they should be recognized as first-line treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyHumansFemaleMiddle AgedMaleRandomized Controlled Trials as TopicAdult

Autor:innen und Institutionen

  • Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
  • World Health Organization Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Veron…
  • Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Italy.
  • Section of Oncology, Department of Engineering for Innovation Medicine, University of Verona Hospital Trust, Verona, Italy.
  • Section of Radiotherapy, Department of Medicine, University of Verona Hospital Trust, Verona, Italy.
  • Division of General and Hepatobiliary Surgery, Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.

Zitieren

APA

Turri, G., Ostuzzi, G., Vita, G., Barresi, V., Scarpa, A., Milella, M., Mazzarotto, R., Ruzzenente, A., Barbui, C., & Pedrazzani, C. (2024). Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy. JAMA Network Open, 7(6), e2414702. https://doi.org/10.1001/jamanetworkopen.2024.14702

Vancouver

Turri G, Ostuzzi G, Vita G, Barresi V, Scarpa A, Milella M, et al. Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy. JAMA Network Open. 2024;7(6):e2414702. doi:10.1001/jamanetworkopen.2024.14702

BibTeX
@article{Turri2024,
  author = {Turri, Giulia and Ostuzzi, Giovanni and Vita, Giovanni and Barresi, Valeria and Scarpa, Aldo and Milella, Michele and Mazzarotto, Renzo and Ruzzenente, Andrea and Barbui, Corrado and Pedrazzani, Corrado},
  title = {Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {6},
  pages = {e2414702},
  doi = {10.1001/jamanetworkopen.2024.14702}
}
Kostenlos starten →